Citations

Showing 10 of 108081 citations.

Pap test and a new biomarker-based technology for enhancing the visibility of abnormal cells
Sundeen, Joseph E., Smith, Wendy M. , Marković, Nataša , Marković, Olivera , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 9561-9561

10.1200/jco.2004.22.90140.9561 Get It

Methylation of the mitotic checkpoint genes BUB3 and BUBR1 in lung cancer
Alzein, N. J., Deursen, Jan van, Molina, Julian R.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 9558-9558

10.1200/jco.2004.22.90140.9558 Get It

Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS)-IV experience
Breitfeld, P P, Anderson, J R , Rodeberg, David A. , Qualman, S., Wolden, S., Meyer, William H. , Kao, Simon C.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 8513-8513

10.1200/jco.2004.22.90140.8513 Get It

Cancer patient perspective on an anthology addressing end-of-life care: A qualitative study of The Art of Oncology, When the Tumor is Not the Target
Vickers, Kristin S. , Hathaway, Julie, Clark, Matthew M. , Britt, Teresa, Looker, Sherry, Johnson, P., Moynihan, Timothy J. , Loprinzi, Charles L. , Patten, Christi A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 8208-8208

10.1200/jco.2004.22.90140.8208 Get It

Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials
Mandrekar, Sumithra J. , Dy, Grace K. , Furth, Alfred, Bekele, Lishan, Hanson, L., Sloan, Jeff A. , Adjei, Alex A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 8053-8053

10.1200/jco.2004.22.90140.8053 Get It

A meta-analysis comparing the efficacy of five 5-HT3-receptor antagonists (5-HT3-RAs) for acute chemotherapy induced emesis
Jordan, Karin , Hinke, Axel , Grothey, Axel , Schmoll, Hans‐Joachim

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 8048-8048

10.1200/jco.2004.22.90140.8048 Get It

Pilot evaluation of paroxetine for alleviation of hot flashes in men
Loprinzi, Charles L. , Barton, Debra L. , Sloan, Jeff A. , Novotny, Paul J. , Carpenter, Lisa A., Gettman, Matthew T., Christensen, Bradley J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 8016-8016

10.1200/jco.2004.22.90140.8016 Get It

A phase II study of aerosolized GM-CSF in the treatment of metastatic melanoma to the lung
Dalton, Robert J., Allred, Jacob B., Nevala, Wendy K. , Fitch, Tom R., Egner, James R., Ebbert, Larry P., Markovic, Svetomir N. , Suman, Vera J. , Celis, Esteban , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 7571-7571

10.1200/jco.2004.22.90140.7571 Get It

Adjuvant nodal radiotherapy for node positive head and neck melanoma: A single institution experience
Huber, M. R., Markovic, S. N.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 7537-7537

10.1200/jco.2004.22.90140.7537 Get It

Phase 2 study of PS-341 (bortezomib) in the treatment of metastatic malignant melanoma (MMM)
Geyer, Susan M. , Markovic, Svetomir, Fitch, Tom R., Albertini, Mark R. , Maples, William J., Fracasso, Paula M. , Erlichman, Charles , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 7526-7526

10.1200/jco.2004.22.90140.7526 Get It